Review: ACE inhibitors, but not angiotensin II receptor antagonists, reduce all cause mortality in diabetic nephropathy

Evidence-Based Medicine

Volumn 10, Issue 3, 2005, Pages 77-

  Lerma, Edgar V ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

CAUSE OF DEATH; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; META ANALYSIS; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PROTEINURIA; RENAL PROTECTION; RISK REDUCTION; SHORT SURVEY; SYSTEMATIC REVIEW;

EID: 22444438225     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.10.3.77     Document Type: Short Survey

References (4)

1. Brenner BM, Cooper ME, de Zeeuw D, et al. N Engl J Med 2001;345:861-9.
2. Lewis EJ, Hunsicker LG, Bain RP, et al. N Engl J Med 1993;329:1456-62.
3. Ravid M, Savin H, Jutrin I, et al. Ann Intern Med 1993;118:577-81.
4. Lewis EJ, Hunsicker LG, Clarke WR, et al. N Engl J Med 2001;345:851-60.